Previous 10 | Next 10 |
Image source: The Motley Fool. AtriCure, inc (NASDAQ: ATRC) Q3 2021 Earnings Call Nov 3, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: AtriCure, inc (ATRC) Q3 2021 Earnings Call Transcript
AtriCure, Inc. (ATRC) Q3 2021 Earnings Conference Call November 3, 2021 4:30 PM ET Company Participants Marissa Bych - Investor Relations Mike Carrel - President and Chief Executive Officer Angie Wirick - Chief Financial Officer Conference Call Participants Matthew O'Brien – Piper Sand...
AtriCure (NASDAQ:ATRC): Q3 GAAP EPS of $2.11. Revenue of $70.46M (+28.7% Y/Y) Press Release For further details see: AtriCure reports Q3 results
AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced third quarter 2021 financial results. “Our results were driven by strong growth across key product lines, incl...
AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it will release third quarter 2021 financial results on Wednesday, November 3, 2021. AtriCure will host a confer...
AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that the company will be participating in the upcoming Morgan Stanley 19 th Annual Global Healthcare Confere...
The following slide deck was published by AtriCure, Inc. in conjunction with their 2021 Q2 earnings call. For further details see: AtriCure, Inc. 2021 Q2 - Results - Earnings Call Presentation
AtriCure, Inc. (ATRC) Q2 2021 Earnings Conference Call August 4, 2021 4:30 PM ET Company Participants Lynn Lewis – Investor Relations Mike Carrel – President and Chief Executive Officer Angie Wirick – Chief Financial Officer Conference Call Participants Rick Wise –...
Image source: The Motley Fool. AtriCure, inc (NASDAQ: ATRC) Q2 2021 Earnings Call Aug 4, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: AtriCure, inc (ATRC) Q2 2021 Earnings Call Transcript
AtriCure (NASDAQ:ATRC): Q2 GAAP EPS of -$0.36 misses by $0.02. Revenue of $71.4M (+74.9% Y/Y) beats by $10.32M. Press Release For further details see: AtriCure EPS misses by $0.02, beats on revenue
News, Short Squeeze, Breakout and More Instantly...
Worldwide revenue of $116.3 million – an increase of 15.2% year over year Positive cash flow generation of $8.1 million in second quarter 2024 AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), l...
CFSB Bancorp Inc. (CFSB) is expected to report for Q4 2024 Big 5 Sporting Goods Corporation (BGFV) is expected to report $-0.48 for Q2 2024 Canadian Pacific Kansas City Limited (CP) is expected to report $0.74 for Q2 2024 Captivision Inc. (CAPT) is expected to report for quarter end 2...
AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating in the upcoming Canaccord Genuity 44th...